​ Conditions: Locally Advanced Pancreatic Ductal Adenocarcinoma; Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Interventions: Drug: FMT combined with chemotherapy plus immunotherapy; Drug: Chemotherapy+Immunotherapy

Sponsors: Tianjin Medical University Cancer Institute and Hospital

Not yet recruiting Conditions: Locally Advanced Pancreatic Ductal Adenocarcinoma; Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions: Drug: FMT combined with chemotherapy plus immunotherapy; Drug: Chemotherapy+Immunotherapy
Sponsors: Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting